Insights

Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.

Interstitial Lung Disease: Risk Factors and Comorbidities
July 24, 2019 – 
Key opinion leaders share insight on the risk factors tied to interstitial lung disease (ILD), as well as its potential comorbidities.
An Overview of Interstitial Lung Disease
July 24, 2019 – 
A comprehensive review of interstitial lung disease, its classifications, and who is involved in the management of patients.
The Future of Atopic Dermatitis Management
July 11, 2019 – 
A discussion on the future treatment landscape of atopic dermatitis in adolescents.
Recommendations for Prescribing Dupilumab
July 11, 2019 – 
Key option leaders provide community physicians with recommendations on the management of atopic dermatitis in adolescents with dupilumab.
Multiple Sclerosis: Considerations for Measuring Outcomes
July 09, 2019 – 
Concluding his discussion on the management of multiple sclerosis (MS), Fred D. Lublin, MD, FAAN, FANA, sheds light on optimal outcome measurement.
S1PR Modulators' Role in Treating Multiple Sclerosis
July 09, 2019 – 
An expert shares his perspective on use of sphingosine-1-phosphate receptor (S1PR) modulators in multiple sclerosis.
Dupilumab Efficacy in Treating Adolescents With Atopic Dermatitis
July 03, 2019 – 
A discussion on the efficacy of dupilumab to treat adolescents with atopic dermatitis.
The SOLO 1 and 2 Dupilumab Trial
July 03, 2019 – 
A discussion on the SOLO 1 and 2 trial regimen.
Multiple Sclerosis: Evolution in Goals of Therapy
July 02, 2019 – 
A comprehensive review of how treatment goals have evolved for multiple sclerosis given improvements in therapy.
Managing Symptoms in Patients With Multiple Sclerosis
July 02, 2019 – 
Fred D. Lublin, MD, FAAN, FANA, provides consideration for the symptom-based management of patients with multiple sclerosis.
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.